abacdeddf

Amritpal Khalsa

Disclosure: I am in full compliance with all ethics and other policies for Market Realist research analysts. I am not invested in securities that I cover on Market Realist.

More From Amritpal Khalsa

  • Healthcare

    Must-know: Shanghai free trade zone deregulates medical equipment

    The Shanghai zone has been touted as China’s greatest attempt at economic reform since the first special economic zone in Schenzen in 1980.

    By Amritpal Khalsa
  • Healthcare

    St. Jude Medical: Key strategic stock outlook

    Laser focus CEO Dan Starks told an audience last week that excessive focus on emerging markets “fails to appreciate the potential of the medical device industry.” The CEO firmly believes that straying into emerging markets implies a lack of imagination and focus. This is highly controversial, as most medical technology giants have been investing significantly […]

    By Amritpal Khalsa
  • Healthcare

    Must-know: Current medical devices risks and opportunities

    The industry looks to be weathering the Obamacare storm, yet there are still a couple key reasons to be wary of the industry over the coming months.

    By Amritpal Khalsa
  • Healthcare

    Must-know: Renal denervation trials show the therapy is working

    Renal denervation trials are encouraging This therapy to treat hypertension has shown encouraging results in patients in a study released this week from Singapore. Studies are showing a success rate of 85%, and approximately one-third of patients reduced their dependence on medication. Tan Tock Seng hospital chose to try the relatively untested therapy, as more […]

    By Amritpal Khalsa
  • uploads///blood pressure
    Healthcare

    Is renal denervation a new medical device stocks cash cow?

    No US companies have approved renal denervation devices in the US market, but they’re in the process of testing and selling these devices.

    By Amritpal Khalsa
  • Healthcare

    Why medical device companies’ federal contracts will boost stocks

    A group of medical device manufacturers was recently awarded a slew of government contracts for devices, equipment, and supplies.

    By Amritpal Khalsa
  • Healthcare

    Are Covidien’s layoffs good for the medical device industry?

    Covidien (COV) announced that it will lay off a significant amount of employees as part of global restructuring efforts. The initiative aims to save the company up to $300 million a year by fiscal 2018.

    By Amritpal Khalsa
  • Industrials

    Brazil’s medical device industry: Health coverage outlook

    The upward trends of the healthcare market show that Brazil is positive for the medical device industry, suggesting rapid increases in demand as more and more people can afford the devices and pay accordingly.

    By Amritpal Khalsa
  • Industrials

    Brazil’s medical device industry: Market outlook

    Brazil is the largest market for medical devices in South America. This year, the market is expected to reach $8 billion in revenue.

    By Amritpal Khalsa
  • Healthcare

    Must-know: Key export barriers for medical device manufacturers

    Most large U.S. manufacturers have invested significant capital into emerging markets, including Medtronics, Johnson & Johnson, GE, and Stryker.

    By Amritpal Khalsa
  • uploads///israel
    Healthcare

    Why Israel is poised to soon lead medical device industry growth

    Espicom Business Intelligence forecasts the Israeli market to be valued at $1.096 billion in 2016—a 20% increase over five years. The country looks to the medical device industry for a significant amount of growth.

    By Amritpal Khalsa
  • uploads///pricing e
    Healthcare

    Medtronic purchases Cardiocom: Bad for medical device industry?

    Medtronic has always been considered a bellwether for the medical device industry because of its pure focus on the device market. Yet that changed in mid-August, as Medtronic announced its acquisition of Cardiocom.

    By Amritpal Khalsa
  • uploads///Sharpe Ratio Example
    Financials

    Sharpe ratio shows healthcare ETFs are a strong relative investment

    Adjusting performance on a risk basis As new insurees flood the insurance market and baby boomers approach retirement, the healthcare space should expect dramatic increases in demand. Alongside an increase in demand, however, has been a tightening of reimbursement policy and a more stringent regulatory environment. These variables present unique risks and opportunities for healthcare […]

    By Amritpal Khalsa
  • uploads///Sharpe Ratio Formula
    Healthcare

    Why you should use the Sharpe ratio when investing in the medical device industry

    What is a Sharpe ratio? A Sharpe ratio is a tool that measures the amount of returns for each unit of volatility that’s generated by a portfolio (higher returns and lower volatility equals more returns per unit of volatility). The measurement allows investors to analyze how much return they’re receiving from a portfolio in exchange for […]

    By Amritpal Khalsa
  • Healthcare

    Must-know: Insurance exchanges will affect medical device stocks

    Big change to come in the healthcare industry Ready or not, state-run insurance exchanges will be ready for open enrollment starting October 1. The introduction of these public exchanges for individuals and small group employers highlights a significant change in the healthcare industry. Making consumer access to healthcare easier, more than 30 million people are […]

    By Amritpal Khalsa
  • uploads///Repeal Effect on Federal Deficit
    Healthcare

    Why the medical device tax repeal bill shouldn’t pass anytime soon

    The proposed Protect Medical Innovation Act of 2013 The Protect Medical Innovation Act of 2013 has gained bi-partisan support in the House of Representatives, ensuring the bill passes when it comes to vote. But the keyword is “when” it comes to vote. Witnessing large layoffs by companies like Stryker Corp. in November 2012, lawmakers began taking […]

    By Amritpal Khalsa
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.